Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Jun;15(4):573-585.
doi: 10.1007/s11739-020-02288-1. Epub 2020 Feb 10.

Anaemia, iron homeostasis and pulmonary hypertension: a review

Affiliations
Review

Anaemia, iron homeostasis and pulmonary hypertension: a review

Thomas Sonnweber et al. Intern Emerg Med. 2020 Jun.

Abstract

Anaemia is a highly prevalent condition, which negatively impacts on patients' cardiovascular performance and quality of life. Anaemia is mainly caused by disturbances of iron homeostasis. While absolute iron deficiency mostly as a consequence of chronic blood loss or insufficient dietary iron absorption results in the emergence of iron deficiency anaemia, inflammation-driven iron retention in innate immune cells and blockade of iron absorption leads to the development of anaemia of chronic disease. Both, iron deficiency and anaemia have been linked to the clinical course of pulmonary hypertension. Various mechanistic links between iron homeostasis, anaemia, and pulmonary hypertension have been described and current treatment guidelines suggest regular iron status assessment and the implementation of iron supplementation strategies in these patients. The pathophysiology, diagnostic assessment as well as current and future treatment options concerning iron deficiency with or without anaemia in individuals suffering from pulmonary hypertension are discussed within this review.

Keywords: Anaemia; Cardiovascular disease; Hypoxia; Iron deficiency; Pulmonary hypertension.

PubMed Disclaimer

Conflict of interest statement

GW received financial payment for advisory board participation (Vifor Pharma), all other authors declare no conflict of interest connected with this study.

Figures

Fig. 1
Fig. 1
Regulation of iron homeostasis in the human body
Fig. 2
Fig. 2
Current concepts of the interconnection of iron homeostasis, anaemia and pulmonary hypertension. HIF hypoxia-inducible factor, NO nitric oxide, ET1 endothelin 1, PH pulmonary hypertension, ROS reactive oxygen species, RNS reactive nitrogen species, BMP bone morphogenetic protein, SMAD small mothers against decapentaplegic

References

    1. Camaschella C. New insights into iron deficiency and iron deficiency anemia. Blood Rev. 2017;31(4):225–233. doi: 10.1016/j.blre.2017.02.004. - DOI - PubMed
    1. Kassebaum NJ, Jasrasaria R, Naghavi M, Wulf SK, Johns N, Lozano R, Regan M, Weatherall D, Chou DP, Eisele TP, Flaxman SR, Pullan RL, Brooker SJ, Murray CJ. A systematic analysis of global anemia burden from 1990 to 2010. Blood. 2014;123(5):615–624. doi: 10.1182/blood-2013-06-508325. - DOI - PMC - PubMed
    1. Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med. 2005;352(10):1011–1023. doi: 10.1056/NEJMra041809. - DOI - PubMed
    1. Anker SD, Comin Colet J, Filippatos G, Willenheimer R, Dickstein K, Drexler H, Luscher TF, Bart B, Banasiak W, Niegowska J, Kirwan BA, Mori C, von Eisenhart Rothe B, Pocock SJ, Poole-Wilson PA, Ponikowski P, Investigators F-HT. Ferric carboxymaltose in patients with heart failure and iron deficiency. N Engl J Med. 2009;361(25):2436–2448. doi: 10.1056/NEJMoa0908355. - DOI - PubMed
    1. Ruiter G, Manders E, Happe CM, Schalij I, Groepenhoff H, Howard LS, Wilkins MR, Bogaard HJ, Westerhof N, van der Laarse WJ, de Man FS, Vonk-Noordegraaf A. Intravenous iron therapy in patients with idiopathic pulmonary arterial hypertension and iron deficiency. Pulmon Circ. 2015;5(3):466–472. doi: 10.1086/682217. - DOI - PMC - PubMed